BeOne Medicines (ONC) PT Raised to $362 at Bernstein
Tweet Send to a Friend
Bernstein SocGen Group analyst Rebecca Liang raised the price target on BeOne Medicines (NASDAQ: ONC) to $362.00 (from $259.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
